Automated Cell Counting Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables & Accessories), By Application (Blood Analysis, Stem Cell Research), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Automated Cell Counting Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables & Accessories), By Application (Blood Analysis, Stem Cell Research), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Automated Cell Counting Market Growth & Trends

The global automated cell counting market size is expected to reach USD 8.93 billion by 2030, registering a CAGR of 12.45% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing need for biologics in the prevention and treatment of chronic and infectious diseases, increased investment in the biotechnology & biopharmaceutical industries, and the development of advanced cell-based research are some of the factors driving market expansion. Biologics development necessitates the use of various cell counting equipment, including image-based counters and flow cytometers, to manage cell concentration in biologics, hence boosting the market's growth prospects.

The COVID-19 pandemic had an enormous impact on the utilization of cell-counting equipment and consumables. The pandemic saw an increase in the use of cell counting instruments, as osteopenia & lymphopenia were possible COVID-19 indicators. For instance, in June 2021, a study published in the journal BMC Infectious Diseases discovered that a high number of white blood cells upon admission was substantially associated with death in COVID-19 individuals. As a result, a greater number of white blood cells were taken into account when treating COVID-19. Due to such developments, the COVID-19 outbreak had a significant impact on the market growth.

The increased incidence of target diseases such as HIV, measles, diphtheria, & chronic diseases such as cancer and other blood disorders, as well as the increasing utilization of high-throughput flow cytometry & automated hematology analyzers, are the primary factors driving market expansion. According to UNAIDS data, an estimated 38.4 million individuals worldwide were living with HIV in 2022, while an estimated 1.5 million were newly infected with HIV in 2021. As a result, growing infectious illness cases are likely to drive up demand for cell counting instruments and consumables.

Increasing initiatives by leading market players to create improved cell counter devices have resulted in increased popularity of these products due to their numerous applications and ease of use. for example, Mindray introduced the new BC-700 Series in March 2022, an innovative hematology analyzer series that includes complete blood count (CBC) along with erythrocyte sedimentation rate (ESR) assays. Thus, boosting the market growth.

The market is benefiting from increased government & private investment for stem cell, cancer, & immunology research. Automated counting technologies are used in grant programs to advance cell biology and genomics research for applications such as phenotypic identification, cell sorting, as well as single cell analysis. For example, the National Institutes of Health (NIH) granted over $41 billion in healthcare research funding to universities and labs across the US in 2021, a substantial percentage of which was allocated to cell-based research programs. Thus, the availability of such funds and funding enables labs to obtain high-end automated cell analysis tools and further boost market growth.

Automated Cell Counting Market Report Highlights

• Based on product, the consumables and accessories segment is expected to witness the fastest CAGR during the forecast period. The market is expanding due to the repeated procurement of consumables and accessories for automated cell counters
• Based on application, the stem cell research segment is expected to witness the fastest growth during the forecast period. Increased stem cell research and drug development by medical professionals as well as researchers is expected to fuel global market growth
• Based on end-use, the hospitals & diagnostic laboratories segment is expected to witness the fastest growth during the forecast period. The growing prevalence of chronic disorders, the rising number of geriatric population, and others
• North America held the largest revenue share in 2023. This is mostly due to the presence of major market participants and, the rising cost of healthcare in the U.S. and others, which is driving up the market for this region

Please note The report will be delivered in 2-3 business days upon order notification.